Home › Smoldering Multiple Myeloma › Colorado › Denver
Smoldering Multiple Myeloma clinical trials in Denver, CO
3 studies for Smoldering Multiple Myeloma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
RecruitingPhase 3
- Presbyterian - Saint Lukes Medical Center - Health One, Denver
- The Melanoma and Skin Cancer Institute, Englewood · 6 mi away
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
RecruitingPhase 2
- Colorado Blood Cancer Institute, Denver
Smoldering Multiple Myeloma trials in other cities
- New York City, NY6 studies
- Boston, MA6 studies
- Atlanta, GA5 studies
- Columbus, OH3 studies
- Edison, NJ3 studies
- Houston, TX3 studies
- Salt Lake City, UT3 studies
- Durham, NC3 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.